QR Pharma Inc. Exclusively Licenses Clinical Stage Compounds Posiphen®, Bisnorcymserine and Phenserine to Treat Alzheimer’s Disease
Read more here
News
TorreyPines Therapeutics Licenses Posiphen®, Bisnorcymcerine and Phenserine to QR Pharma
Read more here
Jenrin Discovery’s Non-Brain Penetrant Cb1 Antagonists Show Beneficial Effects in Treating Diabetes and Obesity
Read more here
InfraScan Launches International Sales of a Handheld Brain Hematoma Detector
Read more here
InfraScanner: Star Trek Style Scanner Looks for Clots
Read more here
NuPathe Inc. CEO to Present at the Leerink Swann Emerging Technologies in Pain Medicine Conference
Read more here
Protez Pharmaceuticals to be Acquired by Novartis
Read more here
County Biopharmaceutical Firm Protez to be Bought
Read more here
Novartis to Acquire Protez for Up to $400 Million
Read more here
Tips for Emerging Firms on Obtaining Funding
Read more here